Serono

Serono was a biotechnology company specializing in developing treatments for reproductive health, multiple sclerosis, and other medical conditions. It was known for pioneering advancements in fertility therapies, such as hormone-based treatments. In 2007, Serono was acquired by Merck KGaA, a global pharmaceutical and life sciences company, and later integrated into its operations. Today, its legacy continues within Merck’s portfolio, focusing on innovative medicines and therapies.